SANTA MONICA, Calif., April 5, 2016 /PRNewswire/ -- BIOMEDevice Boston 2016 announces a stimulating keynote address to uncover what lies beyond the digital age and the impact on medical technology. Co-Founder of MIT Media Lab and author of Being Digital, Nicholas Negroponte will present surprising changes and possibilities as our digital civilization evolves. Further, BIOMEDevice Boston will feature two tracks of in-depth conference content, and an expo of more than 300 companies across the medical manufacturing ecosystem.
As part of Massachusetts Medtech Week, BIOMEDevice Boston returns to the Boston Exhibition and Conference Center, April 13-14. For more information and to register for the event, visit: biomedevice.mddionline.com.
A Digital Civilization Leads to Advances in Medtech and Biomedical Innovation
No longer a revolution, digital defines our civilization. We now live in a digital age, to the extent our culture, infrastructure and economy allow. And like air and drinking water, being digital will only be noticed in its absence, not its presence, according to Negroponte. In his keynote presentation, The Digital Civilization, Negroponte gives us a glimpse into the surprising forces of change that he predicts will – and some that already do – affect the planet profoundly, including extreme bionics, real artificial intelligence and connectivity as a human right. The Keynote session will take place Thursday, April 14 at 9:00am.
Healthcare On Demand: Uberization of Medical Technology and What's Next
Another featured session analyzes whether mobile health (mHealth) is the answer. Led by Sridhar Iyengar, Founder of Misfit Wearables and CEO of Elemental Machines, the discussion will be centered around how the consumerization of healthcare is affecting value-based healthcare delivery. Further, as mobile and consumer electronics companies penetrate the medical space, are they better equipped to handle the next generation of devices with larger data sets? Iyengar will be joined by TJ Parker, CEO and Co-Founder of Pilllpack. The session will take place on Thursday, April 14 at 10:25am.
See the Future of Medtech in Action on the Innovation Tour
Beyond a robust educational conference, BIOMEDevice Boston includes an Expo of leading medical technology devices. From 3D printers to motor customization, BIOMEDevice Boston has shortlisted the most innovative products, services, and technologies developed in recent years for the Innovation Prize contest. Attendees will be able to tour the five finalists' booths and vote on their favorite. The Innovation Tour to pick the winner will depart from Center Stage at 1:00pm on Wednesday, April 13. To see the full list of finalists, visit: http://www.qmed.com/mpmn/medtechpulse/meet-biomedevice-boston-innovation-prize-finalists.
As a part of Massachusetts Medtech Week, BIOMEDevice Boston will be co-located with MassMEDIC's 20th annual conference, as well as three other advanced manufacturing events, including: Embedded Systems Conference Boston, Design & Manufacturing New England, and PLASTEC New England.
About Advanced Manufacturing Expos & Conferences
UBM's Advanced Manufacturing portfolio is the leading B-to-B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Advanced Manufacturing portfolio is organized by UBM Americas, a part of UBM plc (UBM.L), an Events First marketing and communication services business. For more information, visit ubmamericas.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/beyond-the-digital-age-at-biomedevice-boston-mit-media-lab-co-founder-nicholas-negroponte-predicts-forces-of-change-ahead-300245890.html
SOURCE UBM Americas